GAFA
ABBV icon

Garton & Associates Financial Advisors’s AbbVie ABBV Stock Holding History

Garton & Associates Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58M Buy
10,238
+7,210
+238% +$1.55M 5.83% 5
2026
Q1 		$659K Sell
3,028
-6,095
-67% -$1.35M 0.54% 49
2025
Q4 		$2.08M Buy
+9,123
New +$2.08M 1.17% 20

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Garton & Associates Financial Advisors's ABBV Position: Q2 2026 in Review

Garton & Associates Financial Advisors increased its AbbVie (ABBV) stake by 238% in Q2 2026, buying an estimated $1.55M and bringing the position to 10,238 shares worth $2.58M. The position accounts for 5.83% of the portfolio, ranked #5.

Garton & Associates Financial Advisors first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Garton & Associates Financial Advisors held 10,238 shares of AbbVie worth $2.58M as of Q2 2026.
  • Garton & Associates Financial Advisors bought 7,210 AbbVie shares in Q2 2026, an estimated $1.55M.
  • AbbVie made up 5.83% of Garton & Associates Financial Advisors's portfolio in Q2 2026, its #5 holding.
  • Garton & Associates Financial Advisors first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Garton & Associates Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.